ASVRX
Price
$9.78
Change
+$0.05 (+0.51%)
Updated
Jun 2 closing price
Net Assets
3.06B
LRSRX
Price
$14.43
Change
+$0.18 (+1.26%)
Updated
Jun 2 closing price
Net Assets
385.88M
Interact to see
Advertisement

ASVRX vs LRSRX

Header iconASVRX vs LRSRX Comparison
Open Charts ASVRX vs LRSRXBanner chart's image
ASVRX vs LRSRX Comparison Chart in %
View a ticker or compare two or three
VS
ASVRX vs. LRSRX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASVRX is a Buy and LRSRX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
ASVRX has more cash in the bank: 3.06B vs. LRSRX (386M). ASVRX pays higher dividends than LRSRX: ASVRX (0.54) vs LRSRX (0.14). ASVRX was incepted earlier than LRSRX: ASVRX (16 years) vs LRSRX (18 years). ASVRX (1.58) is less costly to investors than LRSRX (1.46). LRSRX is a more actively managed with annual turnover of: 69.00 vs. ASVRX (39.00). LRSRX has a lower initial minimum investment than ASVRX: LRSRX (0) vs ASVRX (2500). LRSRX annual gain was more profitable for investors over the last year : 15.46 vs. ASVRX (8.16). ASVRX return over 5 years is better than : -11.82 vs. LRSRX (-16.98).
ASVRXLRSRXASVRX / LRSRX
Total Expense Ratio1.581.46108%
Annual Report Gross Expense Ratio1.581.46108%
Fund Existence16 years18 years-
Gain YTD13.40310.637126%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets3.06B386M792%
Annual Yield % from dividends0.540.14399%
Returns for 1 year8.1615.4653%
Returns for 3 years11.3516.6968%
Returns for 5 years-11.82-16.9870%
Returns for 10 years26.97-32.74-82%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SDOT3.280.18
+5.81%
Sadot Group Inc.
FBIO2.650.08
+3.11%
Fortress Biotech
ARCC18.97-0.10
-0.52%
Ares Capital Corp
WU7.97-0.18
-2.21%
Western Union Company (The)
EDIT2.82-0.53
-15.72%
Editas Medicine